BE803803A - Nouvelles piperazino-pyrimidines utilisables comme medicaments - Google Patents

Nouvelles piperazino-pyrimidines utilisables comme medicaments

Info

Publication number
BE803803A
BE803803A BE134751A BE134751A BE803803A BE 803803 A BE803803 A BE 803803A BE 134751 A BE134751 A BE 134751A BE 134751 A BE134751 A BE 134751A BE 803803 A BE803803 A BE 803803A
Authority
BE
Belgium
Prior art keywords
pyrimidines
medicinal products
piperazino
new
new piperazino
Prior art date
Application number
BE134751A
Other languages
English (en)
French (fr)
Inventor
G Loiseau
G Mattioda
R Millischer
P Obellianne
Original Assignee
Ugine Kuhlmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ugine Kuhlmann filed Critical Ugine Kuhlmann
Publication of BE803803A publication Critical patent/BE803803A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BE134751A 1973-07-06 1973-08-20 Nouvelles piperazino-pyrimidines utilisables comme medicaments BE803803A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7324874A FR2257294B1 (xx) 1973-07-06 1973-07-06

Publications (1)

Publication Number Publication Date
BE803803A true BE803803A (fr) 1974-02-20

Family

ID=9122191

Family Applications (1)

Application Number Title Priority Date Filing Date
BE134751A BE803803A (fr) 1973-07-06 1973-08-20 Nouvelles piperazino-pyrimidines utilisables comme medicaments

Country Status (10)

Country Link
JP (1) JPS5849548B2 (xx)
BE (1) BE803803A (xx)
CH (1) CH582171A5 (xx)
DE (1) DE2342880A1 (xx)
ES (1) ES418113A1 (xx)
FR (1) FR2257294B1 (xx)
GB (1) GB1434544A (xx)
LU (1) LU68263A1 (xx)
MX (1) MX2978E (xx)
NO (1) NO137205C (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH602663A5 (xx) * 1975-05-23 1978-07-31 Mar Pha Etu Expl Marques
FR2417507A2 (fr) * 1977-07-28 1979-09-14 Ugine Kuhlmann Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides
JPS54159877A (en) * 1978-06-07 1979-12-18 Matsushita Electronics Corp Detection method for semiconductor substrate position and break
FR2503162A1 (fr) * 1981-04-07 1982-10-08 Pharmindustrie Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments
JPS6177335A (ja) * 1984-09-25 1986-04-19 Kazumichi Kimura 半導体ペレツト不良マ−ク検出装置
IT1191845B (it) * 1986-01-20 1988-03-23 Dompe Farmaceutici Spa Alchiloli derivati farmacologicamente attivi
JPH02114936U (xx) * 1989-03-03 1990-09-14

Also Published As

Publication number Publication date
GB1434544A (en) 1976-05-05
MX2978E (es) 1980-01-17
JPS5849548B2 (ja) 1983-11-05
FR2257294A1 (xx) 1975-08-08
JPS5025578A (xx) 1975-03-18
FR2257294B1 (xx) 1977-07-01
NO137205C (no) 1978-01-18
DE2342880A1 (de) 1975-01-30
NO326073L (xx) 1975-02-03
ES418113A1 (es) 1976-03-16
CH582171A5 (xx) 1976-11-30
NO137205B (no) 1977-10-10
LU68263A1 (xx) 1973-10-24

Similar Documents

Publication Publication Date Title
BE824359A (fr) Derives biphenyles utiles comme medicaments
FR2285895A1 (fr) Supports pour medicaments
FR2276811A1 (fr) Feuilles servant de supports pour substances actives de medicaments
BE823689A (fr) Compositions pharmaceutiques
BE829845A (fr) Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants
FR2352808A1 (fr) Acides 12-azaprostanoiques utiles comme medicaments
AT353972B (de) Zahnpflegemittel
BE803804A (fr) Nouvelles methylthio-5 pyrimidines utilisables comme medicaments
AT335619B (de) Zahnpflegemittel
FR2308361A1 (fr) Nouvelles 3,4-dihydrospiro-2h-1,3-benzoxazines utiles comme medicaments
FR2353540A1 (fr) Nouveaux benzamides applicables comme medicaments
BE803803A (fr) Nouvelles piperazino-pyrimidines utilisables comme medicaments
BE816214A (fr) Nouvelles compositions therapeutiques
BE832277R (fr) Nouvelles piperazilo-pyrimidines utilisables comme medicaments
BE825135A (fr) Derives de la benzofurannone utilisables comme medicaments
AT344916B (de) Zahnpflegemittel
BE817427A (fr) Compositions pharmaceutiques
BE816445A (fr) Derives bis-amines utiles comme medicaments
SE7711779L (sv) Farmaceutiska kompositioner
BE769609A (fr) Nouveaux composes cepheme utiles comme medicaments
FR2315259A1 (fr) Nouvelles amidines terpenoaromatiques utilisables comme medicaments
FR2332017A1 (fr) Antibiotiques de type thienamycine utiles comme medicaments
BE830383A (fr) Compositions aqueuses de rafoxanide utiles comme medicaments
BE814089A (fr) Nouvelles seco-prostaglandines utiles comme medicaments et procede pour leur preparation
AT335620B (de) Zahnpflegemittel

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MAR-PHA

Effective date: 19870831